Foghorn Therapeutics Inc. - Common Stock (FHTX) — AI analysis & news
Foghorn Therapeutics Inc. - Common Stock (FHTX) stock: 6 recent news items, negative aggregate sentiment, AI analysis and market context on BestAIBroker.
Current sentiment read
Across the last 6 indexed FHTX stories, aggregate finance-aware sentiment is negative (-0.52 on a -1 to +1 scale).
Why FHTX moved
Last significant move: -30.82% (negative).
FHTX's 30.8% bearish movement is primarily driven by the termination of its collaboration with Lilly, leading Wedbush to slash its price target by 80% and downgrade the stock from ‘Outperform’ to ‘Neutral.’ This development undermines the previous bullish outlook, triggering a sharp sell-off and rating downgrades from analysts such as BTIG.
Latest FHTX news
- Why is Foghorn Therapeutics stock plunging today? - Investing.com · Investing.com
- Why is Foghorn Therapeutics stock plunging today? - Investing.com India · Investing.com India
- Stifel cuts Foghorn Therapeutics stock price target on pipeline shift - Investing.com India · Investing.com India
- Why is Foghorn Therapeutics stock plummeting today? - Investing.com · Investing.com
- Why is Foghorn Therapeutics stock plummeting today? By Investing.com - Investing.com India · Investing.com India
- Citizens reiterates Foghorn Therapeutics stock rating on trial data - Investing.com India · Investing.com India
FAQ
What is the current sentiment for FHTX stock?
Aggregate finance-aware sentiment across the last 6 indexed FHTX news stories is negative (-0.52 on a -1 to +1 scale).
Why did FHTX stock move recently?
FHTX last moved -30.82% (negative). FHTX's 30.8% bearish movement is primarily driven by the termination of its collaboration with Lilly, leading Wedbush to slash its price target by 80% and downgrade the stock from ‘Outperform’ to ‘Neutral.’ This development undermines the previous bullish outlook, triggering a sharp sell-off and rating downgrades from analysts such as BTIG.